Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 26 Feb 2024

Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay

in Cancer Molecular Targets and Therapeutics

Huiming Zhang
Naifeng Chen
Chenglong Ding
Huinan Zhang
Dejiang Liu
Shuang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1344290

4,436 views
4 citations

Mini Review

Published on 26 Feb 2024

In vitro and in vivo modeling systems of supratentorial ependymomas

in Cancer Molecular Targets and Therapeutics

Emily A. Hatanaka
Joshua J. Breunig

Frontiers in Oncology

doi 10.3389/fonc.2024.1360358

1,808 views

Original Research

Published on 26 Feb 2024

Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro

in Cancer Molecular Targets and Therapeutics

Natália V. Segatto
Lucas D. Simões
Camila B. Bender
Fernanda S. Sousa
Thais L. Oliveira
Júlia D. F. Paschoal
Bruna S. Pacheco
Isadora Lopes
Fabiana K. Seixas
Aisha Qazi

Frontiers in Oncology

doi 10.3389/fonc.2024.1323422

2,183 views
1 citation

Correction

Published on 22 Feb 2024

Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

in Cancer Molecular Targets and Therapeutics

Xin Wen
Si Chen
Xueting Chen
Hui Qiu
Wei Wang
Nie Zhang
Wanming Liu
Tingting Wang
Xin Ding
Longzhen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1381151

728 views

Review

Published on 21 Feb 2024

Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review

in Cancer Molecular Targets and Therapeutics

Yingjun Zhang
Ge Zhang
Yuefang Wang
Lei Ye
Luyun Peng
Rui Shi
Siqi Guo
Jiajing He
Hao Yang
Qingkai Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1324859

2,149 views
2 citations

Case Report

Published on 06 Feb 2024

Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation

in Cancer Molecular Targets and Therapeutics

Xiaolin Ren
Kejie Li
Yang Zhang
Changlin Zou
Meng Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1297156

1,485 views

Original Research

Published on 06 Feb 2024

Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer

in Cancer Molecular Targets and Therapeutics

Sathya Neelature Sriramareddy
Majeed Jamakhani
Léa Vilanova
Hélène Brossel
Bernard Staumont
Malik Hamaidia

Frontiers in Oncology

doi 10.3389/fonc.2024.1323313

2,497 views

Original Research

Published on 05 Feb 2024

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs

in Cancer Molecular Targets and Therapeutics

Weiguo Gu
Penghui Liu
Jiaming Tang
Jianfei Lai
Siya Wang
Jiaming Zhang
Jinbiao Xu
Jianxiong Deng
Feng Yu
Chao Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1288468

2,305 views
2 citations

Case Report

Published on 02 Feb 2024

Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report

in Cancer Molecular Targets and Therapeutics

Huimin Zhang
Xiaofeng Cong
Chen Chen
Ziling Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1325999

1,634 views
1 citation

Original Research

Published on 31 Jan 2024

Outcomes and complications of postoperative seroma cavities following soft-tissue sarcoma resection

in Cancer Molecular Targets and Therapeutics

Logan M. Andryk
John C. Neilson
Adam N. Wooldridge
Donald A. Hackbarth
Meena Bedi
Keith E. Baynes
John A. LoGiudice
Sonia M. Slusarczyk
David M. King

Frontiers in Oncology

doi 10.3389/fonc.2024.1250069

4,900 views

Review

Published on 30 Jan 2024

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours

in Cancer Molecular Targets and Therapeutics

Kamilla JA. Bigos
Conrado G. Quiles
Sapna Lunj
Danielle J. Smith
Mechthild Krause
Esther GC. Troost
Catharine M. West
Peter Hoskin
Ananya Choudhury

Frontiers in Oncology

doi 10.3389/fonc.2024.1331355

7,554 views
11 citations

Original Research

Published on 24 Jan 2024

The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma

in Cancer Molecular Targets and Therapeutics

Junjian Yu
Wenyu Jia
Qi Liu
Antai Yuan
Zhuoyu Jia
YuQi Sun
Zequn Li
Shougen Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1347270

1,180 views
1 citation

Case Report

Published on 24 Jan 2024

Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Yajun Liang
Liya Hu
Huanlei Wu
Tiejun Yin
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1292319

1,932 views
1 citation

Original Research

Published on 24 Jan 2024

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors

in Cancer Molecular Targets and Therapeutics

Yu Wang
Shunsuke Shimosaki
Emi Ikebe
Hidekatsu Iha
Jun-ichi Yamamoto
Nichole Fife
Tomonaga Ichikawa
Mitsuo Hori
Masao Ogata
Yoshiyuki Tsukamoto

Frontiers in Oncology

doi 10.3389/fonc.2023.1272528

2,760 views
1 citation

Review

Published on 22 Jan 2024

Pediatric low-grade glioma models: advances and ongoing challenges

in Cancer Molecular Targets and Therapeutics

Griselda Metta Yvone
Joshua J. Breunig

Frontiers in Oncology

doi 10.3389/fonc.2023.1346949

3,054 views
5 citations

Case Report

Published on 22 Jan 2024

Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis

in Cancer Molecular Targets and Therapeutics

Majd Al Assaad
Nara Shin
Michael Sigouros
Jyothi Manohar
Zoia Antysheva
Nikita Kotlov
Daria Kiriy
Anastasiia Nikitina
Mikhail Kleimenov
Anastasiya Tsareva

Frontiers in Oncology

doi 10.3389/fonc.2023.1274163

2,103 views
1 citation

Navigation group

Articles

Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay

In vitro and in vivo modeling systems of supratentorial ependymomas

Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro

Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review

Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation

Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs

Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report

Outcomes and complications of postoperative seroma cavities following soft-tissue sarcoma resection

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours

The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma

Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors

Pediatric low-grade glioma models: advances and ongoing challenges

Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis